Insider Transactions in Q1 2025 at Gemini Therapeutics, Inc. (GMTX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Rahul Khara Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,161
-3.0%
|
$62,694
$54.58 P/Share
|
|
Feb 18
2025
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,137
-4.32%
|
$169,398
$54.58 P/Share
|
|
Feb 18
2025
|
Jean M. Franchi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,136
-4.32%
|
$169,344
$54.58 P/Share
|
|
Feb 18
2025
|
Jonathan Yen Wen Yu Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,610
-3.82%
|
$86,940
$54.58 P/Share
|
|
Feb 18
2025
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,638
-2.34%
|
$88,452
$54.58 P/Share
|
|
Feb 18
2025
|
John D Quisel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,574
-3.48%
|
$300,996
$54.58 P/Share
|
|
Feb 10
2025
|
Pamela Stephenson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+33.13%
|
-
|
|
Feb 10
2025
|
Jonathan Yen Wen Yu Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+36.27%
|
-
|
|
Feb 10
2025
|
Rahul Khara Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+38.69%
|
-
|
|
Feb 10
2025
|
John D Quisel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,337
+32.81%
|
-
|
|
Feb 10
2025
|
Jean M. Franchi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+33.13%
|
-
|
|
Feb 10
2025
|
William Jacob Savage Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+25.5%
|
-
|
|
Feb 03
2025
|
William Jacob Savage Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,731
+5.9%
|
$11,462
$2.65 P/Share
|
|
Feb 03
2025
|
Rahul Khara Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,500
-18.92%
|
$412,500
$55.71 P/Share
|
|
Feb 03
2025
|
Rahul Khara Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+25.83%
|
$105,000
$14.69 P/Share
|
|
Jan 02
2025
|
Rahul Khara Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,500
-13.19%
|
$472,500
$63.01 P/Share
|
|
Jan 02
2025
|
Rahul Khara Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+25.83%
|
$105,000
$14.69 P/Share
|